Sorafenib (Compound)

Synonyms:Sorafenib, 284461-73-0, Nexavar, BAY 43-9006, 4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE, sorafenibum, 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide, Sorafenib free base, 100012-18-8, N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea, 284461-73-0 (free base), MFCD06411450, 4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide, BAY-43-9006, 9ZOQ3TZI87, CHEMBL1336, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide, 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE, DTXSID7041128, CHEBI:50924, Sorafenib [INN], 2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide, Sorafenib (Nexavar), 4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide, Donafenib (Sorafenib D3), 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, BAX, 1210608-86-8, NSC-724772, NCGC00167488-01, UNII-9ZOQ3TZI87, Sorafenib [USAN:INN:BAN], SR-00000000529, HSDB 8173, 1uwh, 3gcs, 3heg, 4asd, Hit compound, 8, Sorafenib, 4, 4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N(SUP 2)-METHYLPYRIDINE-2-CARBOXAMIDE, Manganese(4+), chloro[[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl-kappaN21,kappaN22,kappaN23,kappaN24)tetrakis[1-methylpyridiniumato]](2-)]-, chloride (1:4), (SP-5-12)-, BAY 439006, BAY43-9006, Kinome_766, SORAFENIB BASE, SORAFENIB [MI], Sorafenib (USAN/INN), Sorafenib-[13C,d3], SORAFENIB [USAN], Nexavar (TN) (Bayer), SORAFENIB [VANDF], SORAFENIB [MART.], EC 608-209-4, SCHEMBL8218, SORAFENIB [WHO-DD], SORAFENIB [EMA EPAR], BAY 43-9006; Sorafenib, cid_216239, GTPL5711, BDBM16673, BCPP000064, HMS2043A18, HMS3244A15, HMS3244A16, HMS3244B15, HMS3656N20, K00597a, ACT06732, BCP01767, BCP34023, EX-A2894, BAY439006, NSC747971, NSC800934, s7397, STK627350, AKOS005560229, AC-1674, BAY-439006, CCG-269400, CS-1590, DB00398, NSC-747971, NSC-800934, PB14443, SB19942, SF-0529, BAY-43-0006, Sorafenib free base (BAY-43-9006), NCGC00167488-02, NCGC00167488-03, NCGC00167488-04, NCGC00167488-05, NCGC00167488-07, NCGC00167488-14, 4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide, BS164413, HY-10201, N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea, SY009239, AM20090614, FT-0650736, FT-0674632, SW202562-4, D08524, EN300-120647, AB00933189-05, AB00933189-06, AB00933189_08, A819449, Q421136, Q-201728, SR-00000000529-1, BRD-K23984367-001-01-8, Z89277543, BAY 439006; BAY439006; BAY-439006, Sorafenib (D3); CM-4307; CM 4307; CM4307;Bay 43-9006 (D3), 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido) phenoxy)-N-methylpicolinamide, 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido)phenoxy)-N-methylpicolinamide, N-(3-trifluoromethyl-4-chlorophenyl)-N'-(4-(2-methylcarbamoyl pyridin-4-yl)oxyphenyl)urea, 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)- N-methylpyridine-2-carboxamide, 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide;tosylic acid, 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide, 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methyl-pyridine-2-carboxamide, Manganese(4+), chloro[[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl-N21,N22,N23,N24)tetrakis[1-methylpyridiniumato]](2-)]-, chloride (1:4), (SP-5-12)-, N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl) urea
Pubchem:PUBCHEM:216239
Id:0f1381ed-87d2-5989-a625-810bf435625c
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Sorafenib's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Sorafenib.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Sorafenib.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.